Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention

Recruiting N/A Interventional Study
HIV Seropositivity
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 49
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
900 (estimated)
Sponsor
University of Chicago · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria for Index Participants: * Aged 18-49 years old, inclusive * Speak English * Own a cell phone not shared with anyone else * Have missed at least one HIV care scheduled visit or have not been virally suppressed in the past 24 months. * Resides in Chicagoland, Illinois or Alabama E…
Contacts

Alida Bouris, PhD

773-834-4304

abouris@uchicago.edu

CONTACT

David S Batey, PhD

504-862-3485

dsbatey@tulane.edu

CONTACT